| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.65e-04 | 130 | 7 | 2 | GO:0005200 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.60e-03 | 227 | 7 | 2 | GO:0051015 | |
| GeneOntologyBiologicalProcess | actin filament capping | 1.01e-04 | 46 | 7 | 2 | GO:0051693 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.30e-04 | 52 | 7 | 2 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.79e-04 | 61 | 7 | 2 | GO:0030834 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.10e-04 | 66 | 7 | 2 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 2.71e-04 | 75 | 7 | 2 | GO:0030837 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 3.81e-04 | 89 | 7 | 2 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 3.99e-04 | 91 | 7 | 2 | GO:0032272 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 4.81e-04 | 100 | 7 | 2 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 5.30e-04 | 105 | 7 | 2 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 9.93e-04 | 144 | 7 | 2 | GO:0043244 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.93e-04 | 144 | 7 | 2 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 1.16e-03 | 156 | 7 | 2 | GO:0030833 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 1.43e-03 | 173 | 7 | 2 | GO:0031333 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.49e-03 | 177 | 7 | 2 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 1.55e-03 | 180 | 7 | 2 | GO:0030832 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 1.72e-03 | 190 | 7 | 2 | GO:0030041 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.79e-03 | 194 | 7 | 2 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.85e-03 | 197 | 7 | 2 | GO:1902904 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 2.34e-03 | 222 | 7 | 2 | GO:0008154 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.53e-03 | 231 | 7 | 2 | GO:0032271 | |
| MousePheno | dilated liver sinusoidal space | 1.72e-04 | 48 | 6 | 2 | MP:0000602 | |
| MousePheno | increased B cell proliferation | 4.20e-04 | 75 | 6 | 2 | MP:0005154 | |
| MousePheno | abnormal liver sinusoid morphology | 4.66e-04 | 79 | 6 | 2 | MP:0008989 | |
| MousePheno | abnormal liver vasculature morphology | 8.69e-04 | 108 | 6 | 2 | MP:0009820 | |
| MousePheno | abnormal biliary tract morphology | 1.02e-03 | 117 | 6 | 2 | MP:0005083 | |
| MousePheno | abnormal B cell proliferation | 1.71e-03 | 152 | 6 | 2 | MP:0005153 | |
| MousePheno | abnormal B cell activation | 2.04e-03 | 166 | 6 | 2 | MP:0008217 | |
| MousePheno | abnormal renal tubule morphology | 3.77e-03 | 227 | 6 | 2 | MP:0002703 | |
| MousePheno | abnormal liver lobule morphology | 3.84e-03 | 229 | 6 | 2 | MP:0008987 | |
| MousePheno | abnormal liver parenchyma morphology | 4.31e-03 | 243 | 6 | 2 | MP:0008986 | |
| Pubmed | 6.59e-06 | 20 | 7 | 2 | 18723693 | ||
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 5.55e-06 | 14 | 7 | 2 | M2442 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE | 6.53e-04 | 148 | 7 | 2 | M39021 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL | 7.43e-04 | 158 | 7 | 2 | M39047 | |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 8.80e-04 | 172 | 7 | 2 | M8234 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 1.13e-03 | 195 | 7 | 2 | M7397 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP | 1.15e-03 | 197 | 7 | 2 | M6081 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP | 1.16e-03 | 198 | 7 | 2 | M5287 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP | 1.16e-03 | 198 | 7 | 2 | M7550 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | 1.17e-03 | 199 | 7 | 2 | M6199 | |
| Coexpression | GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN | 1.17e-03 | 199 | 7 | 2 | M3533 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN | 1.17e-03 | 199 | 7 | 2 | M8289 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_DN | 1.17e-03 | 199 | 7 | 2 | M5439 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_DN | 1.17e-03 | 199 | 7 | 2 | M5414 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.19e-03 | 200 | 7 | 2 | M5063 | |
| Coexpression | GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP | 1.19e-03 | 200 | 7 | 2 | M9899 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M8328 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 1.19e-03 | 200 | 7 | 2 | M7020 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B2_BCELL_UP | 1.19e-03 | 200 | 7 | 2 | M6462 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.19e-03 | 200 | 7 | 2 | M6619 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.19e-03 | 200 | 7 | 2 | M4456 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.19e-03 | 200 | 7 | 2 | M8032 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP | 1.19e-03 | 200 | 7 | 2 | M6094 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP | 1.19e-03 | 200 | 7 | 2 | M3636 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP | 1.19e-03 | 200 | 7 | 2 | M3633 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M8968 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 72 | 7 | 2 | 78e158835ec2a37faadf5acdbb62f266cc184e44 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 72 | 7 | 2 | 5e5eb8c7014396767f3dc7d99cb552edd273bfbd | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 72 | 7 | 2 | c4bf1d59845fa54aeb2c8ebeda17bba6641cfb3d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.54e-04 | 123 | 7 | 2 | 12b87d06e62f142e18424aae5c87454e78e713f0 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.75e-04 | 131 | 7 | 2 | c847dcdfb94feb9e1dfc072a162d2b1b6f3d59e4 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 153 | 7 | 2 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | E15.5-Hematopoietic|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.51e-04 | 157 | 7 | 2 | 6315aef4b9bf673069d43a730d4e940011509ac1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 163 | 7 | 2 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-04 | 168 | 7 | 2 | c833e3311af2582787d3ff2ad59d802fff865f8f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 169 | 7 | 2 | cc1b60eb50a274ffd72c67082c19e43af775e949 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Late_pro-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 170 | 7 | 2 | ad69ebfda452e19eedc453e1d07dacb844d64e47 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-04 | 171 | 7 | 2 | a350a5f840e0fb0ccd29bb29cacc23a89abd8404 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.98e-04 | 171 | 7 | 2 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-04 | 171 | 7 | 2 | e0a99ca8d4c86b58f54af7755ffd8e0ffbfae5e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-04 | 171 | 7 | 2 | 58bdcbc65062ac09f1c014e08302f938a3e6b252 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 172 | 7 | 2 | 001d2553a0b5dae3269727bda8ef8067deebab0d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 176 | 7 | 2 | f163cc6d632112aad35a0a9217c6c99fbdd1386e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-04 | 178 | 7 | 2 | 8545c0238d8d833a6a179872d44bfb739310ea17 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-04 | 180 | 7 | 2 | 36e8606893cfb055d38f5a76a8f0c5e1742f3df7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-04 | 180 | 7 | 2 | e76ccbaba18ff27abbd71a41fd3574a5ac5c8fb4 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 181 | 7 | 2 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 186 | 7 | 2 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 186 | 7 | 2 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 188 | 7 | 2 | e0184d9f6687d7ecb8fc461294ff7208f49c437c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 189 | 7 | 2 | a12ca69eebc88725272c89d71a57fc6ce0c06813 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 190 | 7 | 2 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 190 | 7 | 2 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 3.71e-04 | 191 | 7 | 2 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-04 | 191 | 7 | 2 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-04 | 192 | 7 | 2 | c1e2a7df7809696c482442665af5c6bb2f0e5bea | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.75e-04 | 192 | 7 | 2 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-04 | 195 | 7 | 2 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-04 | 195 | 7 | 2 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.87e-04 | 195 | 7 | 2 | 8cd7667a65d77dd7b301090a9b65aba254741375 | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.87e-04 | 195 | 7 | 2 | 211eba45a502b961873ca2d4642f7852e6e89d7a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.91e-04 | 196 | 7 | 2 | 0ebf7e5a9281ec1f33dccd1f8895afd513591b91 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | 5dbe38aef369811d981c0109829563ac66dcc684 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.91e-04 | 196 | 7 | 2 | bd482b7df2993d87c0997a40c4cbd34ba07910cb | |
| ToppCell | 10x5'v1-week_12-13|World / cell types per 3 fetal stages;per 3',per 5' | 3.95e-04 | 197 | 7 | 2 | 4b107359f2d703a1d0348932a6b64eb447d30b3d | |
| ToppCell | B_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.95e-04 | 197 | 7 | 2 | cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-04 | 198 | 7 | 2 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.99e-04 | 198 | 7 | 2 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | BLOOD|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.03e-04 | 199 | 7 | 2 | c2816a840ec3862d22e5efa8f0cdd0208635002d | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 4.03e-04 | 199 | 7 | 2 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | 21|World / Age, Tissue, Lineage and Cell class | 4.03e-04 | 199 | 7 | 2 | 8c6517243168de4134e06dbe16ca89b1c2a73179 | |
| ToppCell | Sigmoid-T_cell-Treg|Sigmoid / Region, Cell class and subclass | 4.03e-04 | 199 | 7 | 2 | 972f1306a38aab0ac9df97df67b28a38b6a05606 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 4.03e-04 | 199 | 7 | 2 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Sigmoid-(1)_T_cell-(15)_Treg|Sigmoid / shred on region, Cell_type, and subtype | 4.03e-04 | 199 | 7 | 2 | 0b736634aaac5759776cb8a0110b1f065b486b5f | |
| ToppCell | Biopsy_Control_(H.)|World / Sample group, Lineage and Cell type | 4.03e-04 | 199 | 7 | 2 | 254c255292d9810fcea017526eae5ddb3a465ce3 | |
| ToppCell | Caecum-T_cell-Activated_CD4_T|Caecum / Region, Cell class and subclass | 4.07e-04 | 200 | 7 | 2 | 7de96254a51dee1375a34b5ae680fe9cce1dbebf | |
| ToppCell | Biopsy_Other_PF|World / Sample group, Lineage and Cell type | 4.07e-04 | 200 | 7 | 2 | fc41a9fb855ae5a5c73a769f18ec7a14f42f18ec | |
| ToppCell | Caecum-(1)_T_cell-(11)_Activated_CD4_T|Caecum / shred on region, Cell_type, and subtype | 4.07e-04 | 200 | 7 | 2 | aef861cb03dd4eb6c571af1f7c32fc0166b50b2c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-04 | 200 | 7 | 2 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Transverse-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 4.07e-04 | 200 | 7 | 2 | d89d3c16406d77cb08e1aa00d7df6887a692c337 | |
| ToppCell | (14)_Tcm|World / shred on Cell_type and subtype | 4.36e-04 | 207 | 7 | 2 | 5521742c28b99d5e3119da11bd56a33bd4243bb3 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.75e-05 | 183 | 7 | 3 | 5613_DN | |
| Drug | CID9959010 | 5.97e-05 | 39 | 7 | 2 | CID009959010 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.18e-03 | 173 | 7 | 2 | 1672_UP | |
| Drug | SAHA; Up 200; 10uM; HL60; HT_HG-U133A | 1.20e-03 | 175 | 7 | 2 | 1161_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-03 | 177 | 7 | 2 | 4821_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.26e-03 | 179 | 7 | 2 | 2794_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.26e-03 | 179 | 7 | 2 | 5336_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.27e-03 | 180 | 7 | 2 | 5484_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; HL60; HT_HG-U133A | 1.29e-03 | 181 | 7 | 2 | 6193_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.30e-03 | 182 | 7 | 2 | 7043_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.30e-03 | 182 | 7 | 2 | 3227_UP | |
| Drug | SAHA; Up 200; 10uM; HL60; HT_HG-U133A | 1.31e-03 | 183 | 7 | 2 | 6179_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A | 1.33e-03 | 184 | 7 | 2 | 2669_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.36e-03 | 186 | 7 | 2 | 1612_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.36e-03 | 186 | 7 | 2 | 3518_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.39e-03 | 188 | 7 | 2 | 3770_DN | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.39e-03 | 188 | 7 | 2 | 7104_UP | |
| Drug | Digoxigenin [1672-46-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.42e-03 | 190 | 7 | 2 | 3060_DN | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.42e-03 | 190 | 7 | 2 | 2920_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.44e-03 | 192 | 7 | 2 | 1153_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.44e-03 | 192 | 7 | 2 | 2807_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 6625_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 5418_UP | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 2886_DN | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 5474_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 2230_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 2805_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 5021_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 6626_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2889_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4403_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5692_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 3192_UP | |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5437_DN | |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 7451_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 4979_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 4175_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 6608_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 4971_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 3638_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 5695_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 484_DN | |
| Disease | Liver Cirrhosis, Experimental | 1.32e-02 | 774 | 7 | 2 | C0023893 | |
| Disease | mean platelet volume | 2.23e-02 | 1020 | 7 | 2 | EFO_0004584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDKPPSTMQFEDDDH | 531 | Q9UEY8 | |
| EEEEEKPHMPTEFDF | 156 | Q9BTK6 | |
| KPHMPTEFDFDDEPV | 161 | Q9BTK6 | |
| FKPEIMPDDSVDEFD | 581 | Q68CZ1 | |
| LEDEDPEEMPKSSDF | 666 | Q9Y5F6 | |
| MTEKAPEPHVEEDDD | 1 | P52566 | |
| YLPMVEEDEHEPKFE | 2306 | P02549 | |
| PKIFFDTDDDDDMPH | 271 | Q8NG27 |